0001179110-14-009834.txt : 20140624 0001179110-14-009834.hdr.sgml : 20140624 20140605162022 ACCESSION NUMBER: 0001179110-14-009834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140604 FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELER TIBOR CENTRAL INDEX KEY: 0001429931 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 14893912 MAIL ADDRESS: STREET 1: 30 PARK ROAD CITY: OTTSVILLE STATE: PA ZIP: 18942 4 1 edgar.xml FORM 4 - X0306 4 2014-06-04 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001429931 KELER TIBOR C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 0 1 0 0 Sr. VP & CSO Incentive Stock Option 13.45 2014-06-04 4 A 0 116500 0 A 2015-06-04 2024-06-04 Common Stock 116500 116500 D 25% vest on June 4, 2015 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Avery W. Catlin, attorney in fact for Tibor Keler 2014-06-05